OAS2 was found to be upregulated in AML patients as well as in the TCGA-AML dataset (Figure 4(b,c)) and positively correlated with the SATB1-AS1 expression (Figure 4(d)). This evidence concerns the gene OAS2 and acute myeloid leukemia.